tiprankstipranks
Trending News
More News >
Harvard Apparatus Regenerative Technology (HRGN)
OTHER OTC:HRGN
US Market
Advertisement

Harvard Apparatus Regenerative Technology (HRGN) Income Statement

Compare
104 Followers

Harvard Apparatus Regenerative Technology Income Statement

Last quarter (Q3 2024), Harvard Apparatus Regenerative Technology's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Harvard Apparatus Regenerative Technology's net income was $-1.86M. See Harvard Apparatus Regenerative Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 79.00K$ 87.00K$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 35.00K$ 52.00K$ 107.00K$ 184.00K$ -214.00K
EBITDA
$ -8.80M$ -6.20M$ -8.36M$ -4.69M$ -8.12M
Operating Income
$ -8.99M$ -6.15M$ -8.64M$ -5.33M$ -8.87M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -8.95M$ -6.07M$ -7.98M$ -4.87M$ -8.33M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Harvard Apparatus Regenerative Technology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis